Why Am I So Bloated? The Gut Science Behind Persistent Bloating

Bloating is one of the most common gastrointestinal complaints in the UK — and one of the most poorly understood. It affects an estimated 15 to 30% of the general population regularly, with higher rates in women, people with IBS, and people under chronic stress. It is frequently dismissed as a minor inconvenience or attributed entirely to diet. It is neither.

The science of bloating has advanced considerably in the past two years. A 2025 study published in In Vivo characterised gut microbiota alterations and intestinal barrier markers in functional bloating patients for the first time at species level. Digestive Disease Week 2025 saw Cedars-Sinai researchers present new data on the three distinct gas microtypes that produce bloating through completely different mechanisms — each requiring different treatment. And a broader picture has emerged of bloating as a gut-brain interaction disorder as much as a gut disorder.

Here is the complete, evidence-based explanation of what bloating actually is, what causes it, and what the evidence shows about fixing it.

What Bloating Actually Is

Bloating describes two related but distinct experiences that the research separates carefully:

Functional bloating — a subjective sensation of fullness, pressure, or tightness in the abdomen, without necessarily visible distension. The discomfort is real and often significant, but the abdomen does not appear enlarged.

Abdominal distension — visible or measurable enlargement of the abdominal girth, which may or may not be accompanied by the subjective sensation of bloating.

These two presentations frequently coexist but are not identical — some people experience significant subjective bloating without measurable distension, while others show objectively increased girth without perceiving severe discomfort. The distinction matters because the mechanisms differ.

Functional abdominal bloating and distension are categorised under disorders of gut-brain interaction according to the Rome IV diagnostic criteria. Their physiopathology is complex and not completely clarified, although gut microbiota imbalances play a central role. The treatment of functional abdominal bloating and distension still represents a clinical challenge for both patients and healthcare providers.

The Gut Microbiome: Central to Most Persistent Bloating

The most significant advance in bloating research over the past two years is a clearer understanding of how the gut microbiome drives persistent bloating — not just through gas production, but through effects on barrier integrity, immune activation, and visceral sensitivity.

A 2025 study published in In Vivo — the first to characterise gut microbiota alterations in functional bloating patients at species level using high-resolution intergenic spacer profiling — analysed stool samples from 42 adults diagnosed with functional bloating. The study found significant gut microbiota alterations including reduced microbial diversity, an altered Firmicutes/Bacteroidetes ratio, and reduced levels of beneficial bacteria. Elevated intestinal barrier disruption markers were also found, indicating that impaired gut barrier function is not merely a consequence of bloating but a contributing mechanism.

The practical implication: bloating that persists despite dietary restriction is often not a food problem. It is a microbiome and barrier problem that dietary restriction does not address and can in some cases worsen by further reducing the dietary diversity that supports microbial health. Our companion article on the diet–microbiota connection and IBS risk covers the dietary patterns that support microbial diversity in more detail.

The Three Gas Microtypes: Why Bloating Is Not One Condition

One of the most important clinical advances in understanding bloating came from Cedars-Sinai's Mark Pimentel and colleagues, whose work has redefined how small intestinal bacterial overgrowth is categorised. Presented at Digestive Disease Week 2025, this framework now recognises three distinct gas microtypes that produce bloating through different mechanisms:

Hydrogen-Dominant SIBO

Hydrogen-dominant SIBO is caused by bacteria including E. coli and Klebsiella, which produce hydrogen gas during fermentation of carbohydrates in the small intestine. Common symptoms include bloating, excessive gas, and diarrhoea. This form is often found in patients with IBS-like conditions.

Hydrogen SIBO is the most common and best-understood type. It typically follows acute gastroenteritis — a stomach bug or food poisoning episode triggers antibodies that damage the migrating motor complex (MMC), the wave of muscular contractions that normally clears bacteria from the small intestine between meals. Bacteria accumulate where they should not be, ferment ingested carbohydrates, and produce gas.

Intestinal Methanogen Overgrowth (IMO)

When methane is the dominant gas, the condition is more accurately referred to as Intestinal Methanogen Overgrowth — IMO. Methane is produced by archaea, not bacteria, and is commonly associated with constipation.

Methane gas slows intestinal transit directly — it acts on smooth muscle cells in the intestinal wall, reducing motility. This explains why IMO patients typically present with constipation-predominant symptoms alongside bloating — the two are mechanistically linked rather than coincidental. Standard hydrogen SIBO treatments are often ineffective against IMO because the organisms responsible are archaea, not bacteria, and respond to different antimicrobial agents.

Intestinal Sulphide Overproduction (ISO)

Intestinal sulphide overproduction — ISO — is the newest recognised gas microtype. Before the development of specific breath tests capable of measuring hydrogen sulphide, this form went undetected. Patients with high levels of hydrogen sulphide share symptoms with SIBO including abdominal pain, bloating, gas, and distension — with diarrhoea particularly prominent and severity correlating with hydrogen sulphide levels.

Cedars-Sinai investigators at Digestive Disease Week 2025 found that patients with gastroesophageal reflux disease have significant changes in the small bowel microbiome, including an increase in hydrogen sulphide-producing organisms. Low-dose rifaximin combined with N-acetylcysteine was more effective than rifaximin alone for improving bloating, diarrhoea, and pain in diarrhoea-predominant IBS patients — the NAC appears to break down the mucus barrier, allowing rifaximin to work more effectively against the bacterial culprits.

The clinical significance of recognising these three distinct types is that treatment approaches differ considerably. Using the wrong antimicrobial for the wrong gas type — as frequently happens when SIBO is treated without distinguishing between hydrogen, methane, and sulphide production — produces incomplete or no response.

The Gut Barrier: An Underappreciated Driver

Intestinal barrier dysfunction — commonly called leaky gut — is increasingly recognised as both a contributor to and a consequence of bloating, creating self-reinforcing cycles that dietary changes alone cannot break.

The intestinal barrier is a single-cell-thick layer of epithelial cells connected by tight junction proteins. When these connections are disrupted — through dysbiosis, chronic stress, alcohol, NSAIDs, or certain dietary patterns — bacterial products including lipopolysaccharide pass into systemic circulation, triggering immune activation and low-grade inflammation.

The 2025 In Vivo study found elevated concentrations of intestinal barrier disruption markers in functional bloating patients, confirming that impaired barrier integrity is not merely a consequence of bloating but a contributing mechanism — creating a cycle where dysbiosis disrupts the barrier, barrier disruption worsens immune activation and visceral sensitivity, and heightened visceral sensitivity amplifies the perception of gas-related discomfort.

This cycle explains why bloating often worsens during periods of stress, after antibiotic courses, or during illness — all of which disrupt the gut barrier through different mechanisms. The same gut–barrier–immune axis underlies conditions covered in our piece on the gut–skin connection and eczema.

The Brain-Gut Axis: Why Stress Makes Bloating Worse

Bloating is classified under disorders of gut-brain interaction for good reason — the nervous system's role in bloating is direct and significant.

The gut contains more neurons than the spinal cord — approximately 500 million — and communicates bidirectionally with the brain through the vagus nerve, the enteric nervous system, and the HPA axis. In people with functional bloating, visceral hypersensitivity — an amplified perception of normal gut sensations — is a primary mechanism. The same amount of gas that produces no symptoms in one person produces significant pain and distension in another, because the nervous system's threshold for interpreting gut signals as uncomfortable is different.

Stress activates the HPA axis, releasing cortisol and adrenaline that alter gut motility, increase intestinal permeability, and amplify visceral sensitivity. This is why bloating reliably worsens during periods of psychological stress — not because stress causes gas production directly, but because it alters both the gut environment and the brain's processing of gut signals simultaneously.

The corollary is that interventions targeting the nervous system — slow breathing, vagus nerve activation, mindfulness — can reduce bloating not through any direct effect on the gut microbiome but through modulating the nervous system's response to gut signals. This is not a placebo effect. It reflects the genuine bidirectionality of the gut-brain axis. Practical techniques are covered in our guide to stimulating the vagus nerve.

Common Dietary Triggers: What the Evidence Shows

Dietary factors do contribute to bloating — but as triggers of symptoms in a vulnerable gut rather than as the primary cause of that vulnerability. Understanding this distinction changes how dietary management should be approached.

FODMAPs — fermentable oligosaccharides, disaccharides, monosaccharides, and polyols — are short-chain carbohydrates that are rapidly fermented by gut bacteria, producing gas. They are not inherently harmful, and they feed beneficial bacteria in a healthy gut. In a dysbiotic gut with bacterial overgrowth or visceral hypersensitivity, the same fermentation produces excessive gas and amplified discomfort.

A low-FODMAP diet reduces bloating symptoms in approximately 50 to 75% of IBS patients in clinical trials — the most evidence-backed short-term dietary approach for bloating. However, it is not a permanent solution. Dietary restriction alone does not restore microbiome balance — it reduces fermentation load while the underlying dysbiosis continues. Long-term low-FODMAP eating also reduces beneficial bacterial populations that depend on fermentable carbohydrates for survival.

The evidence-based approach to dietary management of bloating is: short-term FODMAP reduction to reduce acute symptoms, combined with concurrent microbiome restoration, followed by systematic FODMAP reintroduction to identify specific individual triggers rather than eliminating entire food categories permanently.

Ultra-processed foods — emulsifiers in UPFs disrupt the mucus layer and tight junctions of the gut barrier, worsening the barrier dysfunction that amplifies bloating. Reducing UPF intake supports barrier integrity independently of FODMAP content.

Carbonated drinks — introduce gas directly, can worsen bloating acutely, and are worth reducing in people with acute bloating symptoms.

Eating habits — eating quickly, talking while eating, and drinking through straws all increase air swallowing, which contributes to upper gut gas. Slower eating reduces this mechanism regardless of what is eaten.

What Actually Helps: The Evidence

Microbiome Restoration

Restoring a balanced microbiome appears to be the most promising approach for better management of functional abdominal bloating and distension. The interventions with the best evidence:

Dietary fibre diversity — the 30 plants per week framework provides the diverse fermentable substrates that support microbial diversity. This is the most sustainable microbiome restoration strategy available and the foundation of any bloating management programme.

Fermented foods — kefir, yoghurt, kimchi, sauerkraut, and kombucha introduce live bacteria and support microbiome diversity. Start with small amounts and increase gradually to minimise initial bloating from microbiome adjustment.

Targeted probiotics — Lactobacillus plantarum and Bifidobacterium species have the strongest evidence for reducing bloating specifically. Multi-strain formulations are generally preferable to single-strain products. Consistent use for at least eight to twelve weeks is required to assess response.

Gut Barrier Support

Nutrients that support barrier integrity: L-glutamine — the primary fuel source for intestinal epithelial cells — zinc carnosine, which has specific evidence for tight junction support, omega-3 fatty acids, and butyrate from dietary fibre fermentation. Alcohol, NSAIDs, and chronic stress all damage barrier integrity and should be addressed alongside nutritional support.

Motility Support

Poor gut motility allows bacterial accumulation and gas buildup. The migrating motor complex is most active between meals and during sleep.

Eating patterns that support MMC function: leaving three to five hours between meals rather than grazing continuously, avoiding eating in the two hours before sleep, and maintaining consistent meal timing. Vagus nerve stimulation — through slow breathing, humming, and cold water exposure — activates parasympathetic nervous system tone, which supports gut motility directly.

Breathwork and Nervous System Regulation

For bloating driven by visceral hypersensitivity and gut-brain axis dysregulation, nervous system interventions have genuine evidence. Slow diaphragmatic breathing at five to six breaths per minute activates the vagus nerve, reduces cortisol, and modulates the gut-brain signalling that amplifies bloating symptoms. Mindfulness-based approaches have shown statistically significant improvements in IBS symptoms including bloating in multiple randomised trials.

When to See a Doctor

Most bloating is functional — uncomfortable but not dangerous. Some presentations warrant medical assessment:

• Bloating with unintentional weight loss — warrants urgent GP assessment to rule out malignancy.
• Bloating with blood in stool — requires immediate GP referral.
• Bloating with progressive worsening — particularly in people over 50 or with a family history of colorectal cancer.
• Sudden onset severe bloating without prior history — particularly if accompanied by constipation and vomiting, which may indicate bowel obstruction.
• Bloating with significant fatigue and early satiety — may warrant assessment for coeliac disease, which is frequently missed in adults.

Frequently Asked Questions

What is the most common cause of bloating?

The most common causes include gut microbiome dysbiosis — an imbalance in gut bacterial populations that leads to excessive fermentation and gas production — FODMAP sensitivity in people with IBS or SIBO, impaired gut motility that allows gas to accumulate rather than move through, and visceral hypersensitivity, where the nervous system amplifies the perception of normal gut gas. In practice, most persistent bloating involves a combination of these rather than a single cause.

Is bloating always related to food?

No — while food choices can trigger bloating symptoms, they are rarely the root cause of persistent bloating. The underlying drivers — gut microbiome dysbiosis, intestinal barrier dysfunction, motility impairment, and visceral hypersensitivity — are not resolved by dietary restriction alone. Food restriction reduces fermentation load in the short term but does not address why the gut is producing excessive gas or perceiving it as uncomfortable in the first place.

What is SIBO and how does it cause bloating?

SIBO — small intestinal bacterial overgrowth — occurs when bacteria accumulate in the small intestine in larger numbers than normal. These bacteria ferment carbohydrates that should be absorbed before reaching the large intestine, producing gas in the wrong location. There are three distinct types based on the gas produced: hydrogen-dominant SIBO, intestinal methanogen overgrowth producing methane and associated with constipation, and intestinal sulphide overproduction. Each type requires different treatment, and breath testing can distinguish between them.

Does stress cause bloating?

Stress does not directly cause gas production, but it significantly worsens bloating through multiple mechanisms. Cortisol released during stress increases intestinal permeability, alters gut motility, and amplifies visceral sensitivity — the nervous system's tendency to interpret gut signals as painful or uncomfortable. The gut-brain axis is bidirectional, meaning that psychological state directly influences gut function and the perception of gut symptoms.

How long does it take to resolve bloating through dietary changes?

This depends entirely on the underlying cause. Acute dietary-trigger bloating resolves within hours. Bloating from microbiome dysbiosis typically requires weeks to months of consistent dietary improvement and probiotic support to produce meaningful change. SIBO-related bloating usually requires antimicrobial treatment followed by microbiome restoration — dietary changes alone are insufficient for established SIBO.

What probiotics are best for bloating?

The strains with the strongest evidence specifically for bloating are Lactobacillus plantarum, Bifidobacterium infantis, and Bifidobacterium longum. Multi-strain formulations covering both Lactobacillus and Bifidobacterium species are generally more effective than single-strain products. Consistent use for at least eight to twelve weeks is required to assess meaningful response. Starting with a lower dose and building gradually reduces the initial adjustment bloating that some people experience.

The Bottom Line

Persistent bloating is not a diet problem with a diet solution. It is a gut ecosystem problem — involving the microbiome, the intestinal barrier, motility, and the gut-brain axis — that requires an ecosystem approach to resolve.

Dietary management plays a role, but as part of a broader strategy that includes microbiome restoration through fibre diversity and fermented foods, barrier support through targeted nutrition, motility support through eating patterns and vagus nerve activation, and nervous system regulation for those in whom visceral hypersensitivity is a primary driver.

For a structured approach to resolving bloating through gut microbiome restoration and barrier support, the Bloating Reset from the Reset Series™ provides a day-by-day protocol. The Gut Reset covers the foundational dietary and lifestyle habits that support a balanced microbiome long-term.

Related reading: The Gut–Skin Connection: What New Research Says About Eczema · Diet, Microbiota and IBS Risk: What the Connection Means · How to Stimulate the Vagus Nerve: Your Body's Built-In Off-Switch for Stress

Popular Articles